Gdańsk, Poland I 15 September 2026 Recap of WECAN Academy 2026: Strengthening Cancer Advocacy Across Europe and Beyond We are pleased to share that WECAN Academy 2026 proved to be another success this year. This flagship training event took place from 25–28 June 2026 in Gdańsk, Poland, bringing together
EU Research 1 Sept 2026 ECHoS Phase 2 kick-off meeting: WECAN leads a citizens and patients session At the ECHoS II Kick-off Meeting, the Citizens and Patients session launched the concept of the first of the two “expeditions” on Food & Health following food from the soil it
EU Research 1 Sept 2026 Europe charts an ambitious roadmap for the next five years as a European Network of National Cancer Mission Hubs takes shape After supporting the establishment of 17 National Cancer Mission Hubs, the EU project ECHoS starts an ambitious second phase to further expand its network. WECAN Foundation,
Research I 15 June 2026 A remarkable week for EuroACT: EHA 2026, dashboard launch, and scientific publication The past week has marked extraordinary milestones for the EuroACT initiative, with three major achievements reached in rapid succession. First, EuroACT was proudly showcased at the 2026 Congress of the European Hematology Association
Gdańsk, Poland | 25–28 June 2026 WECAN Academy 2026 - Learning Together, Strengthening Advocacy We are pleased to share that preparations for the Academy 2026 are advancing smoothly. This flagship training event will take place from 25–28 June 2026 in Gdańsk, Poland, bringing together patient advocates from across Europe. The
Education, Research I 13 April 2026 CANCERSurvey: We are now recruiting for Cognitive Testing CANCERSurvey is progressing well CancerSurvey is moving forward towards launch this summer. Work is currently focused on final checks to make sure the questionnaire is clear and easy to complete, and that it captures meaningful patient experience data. The
Research I 04 February 2026 OECD cites EuroACT data in the new report on High Value Cancer Care We are proud to share that the Organisation for Economic Co-operation and Development (OECD-OCDE) has published its 2026 report Delivering Hight Value Cancer Care, and EuroACT data has played a key role in shaping it. The report can be accessed here: https://lnkd.in/eRsupumz EuroACT insights
Research I 03 November 2025 Our haematological diseases preprint is now available on Preprints with The Lancet! Read it here: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=5646744 Title: Variation in Use of Patient-Reported Outcome Measures and in Geographical Distribution in Clinical Trials of Selected Malignant and Non-Malignant Haematological Diseases in Europe: Findings from EuroACT This study analysed data
Research I 20 October 2025 Best Poster Award at ESMO 2025! The EuroACT project was featured Sunday 19th October 2025 at ESMO 2025 Congress showcasing our work on mapping the European clinical trial landscape. We are proud to share that our poster received the Best Poster Award, recognising its outstanding clarity of
Research I 18 August 2025 Recognition for EuroACT: Collaborating with OECD on European Health Policy We are pleased to share that the Organisation for Economic Co-operation and Development (OECD) contacted us after discovering our European Atlas on Clinical Trials in Cancer and Hematology (EuroACT) work on our website. This marks an exciting